[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $phvs

Pharvaris N.V. (PHVS) stock surges pre-market after announcing positive topline data from its pivotal Phase X RAPIDe-3 study for deucrictibant in HAE treatment, meeting all efficacy endpoints.

### About $phvs
Pharvaris N.V. is a biotechnology company focused on developing treatments for rare diseases.  

### Insights
- $phvs engagements hit 25.2K which is 1086% higher than it's daily average.
- $phvs creators hit XX which is XXX% higher than it's daily average.
- $phvs creators is up XXXXXX% from the previous month.
- $phvs posts created is up 1140% from the previous month.

### Engagements: XXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$phvs/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$phvs/time-series/interactions.tsv)  
Current Value: XXXXXX  
Daily Average: XXXXX  
X Week: XXXXXX -XX%  
X Month: XXXXXXX +1,007%  
X Months: XXXXXXX +88%  
X Year: XXXXXXX +67%  
1-Year High: XXXXXX on 2025-07-13  
1-Year Low: X on 2025-01-01  

Engagements by network (24h):
X: XXXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$phvs/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$phvs/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX +300%  
X Months: XXXXX +208%  
X Year: XXXXX +223%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-02-24  

Mentions by network (24h):
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$phvs/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$phvs/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $phvs in the last XX hours which is up XXXX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX +28%  
X Month: XX +149%  
X Months: XXX +358%  
X Year: XXX +404%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-02-16  

The most influential creators that mention $phvs in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@monaco_biotech](/creator/twitter/monaco_biotech)   | X    | XXXXX     | X     | XXXXX       |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XXXXX       |
| [@TENETTRADEGROUP](/creator/twitter/TENETTRADEGROUP) | X    | XXXXXX    | X     | XXXXX       |
| [@tenet_research](/creator/twitter/tenet_research)   | X    | XXXXXXX   | X     | XXX         |
| [@doepke_michel](/creator/twitter/doepke_michel)     | X    | XXXXX     | X     | XXX         |
| [@seedytx19](/creator/twitter/seedytx19)             | X    | XXXXX     | X     | XX          |

[View More](/list/creators/$phvs/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$phvs/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$phvs/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% +2%  
X Month: XX% +38%  
X Months: XX% -XX%  
X Year: XX% -XX%  
1-Year High: XXX% on 2024-12-05  
1-Year Low: XX% on 2025-06-23  

Most Supportive Themes:
- Catalyst Watchlist: (30%) Focus on upcoming Phase X and Phase X clinical trial readouts for various biotech companies, including PHVS.
- HAE Competitor Analysis: (25%) Detailed comparison of Hereditary Angioedema (HAE) treatments, including pricing and efficacy, with PHVS mentioned as a competitor.
- Minervini Trend Template: (20%) Inclusion of PHVS in a stock screener based on Mark Minervini's 'Trend Template' criteria, indicating potential technical strength.
  
Most Critical Themes:
- Market Uncertainty: (50%) General market uncertainty is a concern for investors, impacting the biotech sector.
- Analyst Upgrades and Options: (40%) While analyst upgrades and new option listings are positive, they are overshadowed by broader market concerns.
  

### Top $phvs Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Today's WhatsApp: $GRAB +0.19% $QCLS +38.17% 🚀 $IRBT +73.85% $MPLT +32.26% $PHVS +21.81% Best day ever 💵💵💵 Our WhatsApp team had a blast today XXX% return 🚀 Leading the team to profits is so much fun WhatsApp: Add me and send "Hot Stocks" 💰"  
[X Link](https://x.com/Wilbur_Stein11/status/1996414635495608670) [@Wilbur_Stein11](/creator/x/Wilbur_Stein11) 2025-12-04T03:01Z 4338 followers, XXX engagements


"🚀 Strongest stocks of the day Start tracking these today using our free stock screener: $CAPR $KITT $IRBT $VRAX $QCLS $POET $AEVA $PMAX $AVXL $AHMA $PHVS $SERV $RR $AEO $UMAC $BEAM $FTRE $INDI $SYRE $IMNM $IE $AUR $IXHL $MBOT $OMER $SANA $SITM $PRCT $ARWR $KMTS"  
[X Link](https://x.com/stockbasereport/status/1996381806921155069) [@stockbasereport](/creator/x/stockbasereport) 2025-12-04T00:51Z XXX followers, XXX engagements


"@marketwirenews $PHVS (Pharvaris N.V.) Finance Card: - Current Price: $XXXXX (pre-market Dec X 2025) - Market Cap: $1.57B - EPS (TTM): -$3.36 - PE Ratio: N/A - 52-Wk Range: $XXXXX - $XXXXX - Avg Analyst Target: $XXXXX (Leerink: $38) - Recent: Positive RAPIDe-3 data boosted shares"  
[X Link](https://x.com/grok/status/1996346401308258605) [@grok](/creator/x/grok) 2025-12-03T22:30Z 6.7M followers, XX engagements


"BREAKING NEWS: $PHVS PHVS Price Target Alert: $XXXXX. Issued by Leerink Partners Follow for daily #StockNews @grok please provide the finance card for $PHVS"  
[X Link](https://x.com/marketwirenews/status/1996346220827103701) [@marketwirenews](/creator/x/marketwirenews) 2025-12-03T22:30Z 60.7K followers, XXX engagements